| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
in Human Bone
Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrookes Hospital (E.O.A., A.H., J.E.C.), Cambridge; Department of Clinical Chemistry, Royal Liverpool University Teaching Hospital (E.O.A.), Liverpool L7 8XP; and MRC Bone Research Group, Nuffield Orthopaedic Centre, University of Oxford, Redcliffe Hospital (V.K., J.T.T.), Oxford, United Kingdom
Address correspondence and requests for reprints to: Dr. Emmanuel Abu, Department of Clinical Chemistry, Royal Liverpool University Teaching Hospital, Duncan Building, Prescot Street, Liverpool L7 8XP, United Kingdom. E-mail: eoa{at}liverpool.ac.uk
Glucocorticoids have well-documented effects on the skeleton, although their mechanism of action is still poorly understood. The actions of glucocorticoids on bone cells are mediated, in part, directly via specific receptors. The presence of these receptors has been demonstrated in both rodent and human osteoblastic cells in vitro, but their presence in human bone in vivo has not been reported.
In this study, we have used specific affinity purified polyclonal
antibodies to the functional glucocorticoid receptor
(GR
) to
investigate its expression in both developing and adult human bone
using sections of neonatal rib, calvarial, and vertebral bones, tibial
growth plates from adolescents, and iliac crest biopsies from adults
who were to undergo liver transplantation.
In the tibial growth plates, GR
was predominantly expressed in the
hypertrophic chondrocytes within the cartilage. In the primary
spongiosa, the receptor was highly expressed by osteoblasts at sites of
bone modeling. Within the bone marrow, receptors were also detected in
mononuclear cells and in endothelial cells of blood vessels. In the
neonatal rib and vertebrae, GR
was widely distributed at sites of
endochondral bone formation in resting, proliferating, mature, and
hypertrophic chondrocytes. They were also highly expressed in
osteoblasts at sites of bone modeling. At sites of intramembranous
ossification in neonatal calvarial bone and rib periosteum, GR
was
widely expressed in cells within the fibrous tissue and in osteoblasts
at both the bone-forming surface and at modeling sites. In the iliac
crests from adults, GR
was predominantly expressed in osteocytes.
The receptors were not detected in osteoclasts.
Our results show for the first time the presence of the functional
GR
in human bone in situ and suggest that the actions
of glucocorticoids on bone may be mediated, in part, directly via the
GR at different stages of life. The absence of receptor expression in
osteoclasts also suggests that the effects of glucocorticoids on bone
resorption may be mediated indirectly.
This article has been cited by other articles:
![]() |
M. Sbaihi, K. Rousseau, S. Baloche, F. Meunier, M. Fouchereau-Peron, and S. Dufour Cortisol mobilizes mineral stores from vertebral skeleton in the European eel: an ancestral origin for glucocorticoid-induced osteoporosis? J. Endocrinol., May 1, 2009; 201(2): 241 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Tynjala, P Lahdenne, P Vahasalo, H Kautiainen, and V Honkanen Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis Ann Rheum Dis, August 1, 2006; 65(8): 1044 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. J. van der Eerden, M. Karperien, and J. M. Wit Systemic and Local Regulation of the Growth Plate Endocr. Rev., December 1, 2003; 24(6): 782 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Walsh, G. R. Jordan, C. Jefferiss, K. Stewart, and J. N. Beresford High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis Rheumatology, January 1, 2001; 40(1): 74 - 83. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |